Andrew M. Oh

Chief Financial Officer, Rubius Therapeutics (United States).

Companies

Syros Pharmaceuticals, Inc.Board member Sep 19, 2022 to Jun 7, 2024¹
Rubius Therapeutics (United States)Chief financial officer Jul 17, 2018 to May 19, 2020²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSyros Pharmaceuticals, Inc., Board member
2
SEC EDGARRubius Therapeutics (United States), Chief financial officer